Fredrik Järrsten
Director of Finance/CFO chez OREXO AB
Fortune : 36 063 $ au 31/03/2024
Provenance du réseau au premier degré de Fredrik Järrsten
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
17
| Public Company | Pharmaceuticals: Major | 17 |
| Public Company | Financial Conglomerates | 13 | |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna.
2
| Operating Division | Investment Managers | 2 |
Aleris Holding AB
 Aleris Holding AB Medical/Nursing ServicesHealth Services Aleris Holding AB engages in health sector. It provides services in healthcare and mental health on behalf of municipalities, county councils and insurance companies. The company was founded in March 2005 and is headquartered in Stockholm, Sweden.
2
| Holding Company | Medical/Nursing Services | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Fredrik Järrsten via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AEROCRINE AB | Electronic Equipment/Instruments | Director/Board Member Founder | |
Kareo, Inc.
 Kareo, Inc. Packaged SoftwareTechnology Services Kareo, Inc. provides cloud-based medical office software and services platform. Its products include web-based medical billing software, electronic medical records, practice management, and integrated electronic claims processing. The firm offers an integrated solution of products and services designed to help physicians get paid faster, run their business smarter, and provide better care. The company was founded by Daniel Rodrigues in 2004 and is headquartered in Irvine, CA. | Packaged Software | Director/Board Member | |
| PULMONX CORPORATION | Medical Specialties | Director/Board Member Director/Board Member | |
Pure Life Renal, Inc.
 Pure Life Renal, Inc. Medical/Nursing ServicesHealth Services Pure Life Renal, Inc. provides dialysis services. The firm offers the business and operational management tools along with the administrative structure that enable physicians to concentrate on care in a managed environment. The company was founded by Stefano Ciampolini in 2013 and is headquartered in Hollywood, FL. | Medical/Nursing Services | Director/Board Member | |
HealthCap AB
 HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | Investment Managers | Private Equity Investor Private Equity Investor | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Undergraduate Degree | |
| SINO BIOPHARMACEUTICAL LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal Chairman | |
| Karolinska Institutet | College/University | Chairman Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
Karolinska Institutet Holding AB
 Karolinska Institutet Holding AB Investment Trusts/Mutual FundsMiscellaneous Part of Karolinska Institutet Holding AB, Nätverk Karolinska Institutet Science Park AB (KISP) facilitates interaction between academia and industry on Campus Solna. The private company is based in Solna, Sweden. KISP collaborates closely with Karolinska Institutet, Akademiska Hus, and AWL to organize seminars, workshops, and networking events that help researchers, startups, and established companies connect and gain new insights. The CEO of the Swedish company is Karl Johan Ingvar Weigelt. | Investment Trusts/Mutual Funds | Chief Executive Officer General Counsel | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree | |
| Copenhagen Business School | College/University | Graduate Degree Graduate Degree Graduate Degree | |
| University of Uppsala | College/University | Undergraduate Degree Graduate Degree Graduate Degree Doctorate Degree | |
Montreux Equity Partners, Inc.
 Montreux Equity Partners, Inc. Investment ManagersFinance Montreux Equity Partners, Inc. (Montreux Equity Partners) is a Venture Capital firm founded in 1993 by Dan K. Turner. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Analyst | |
| University of Stockholm | College/University | Graduate Degree Undergraduate Degree | |
| University of Lund | College/University | Doctorate Degree Graduate Degree | |
| European Medical Device Industry Association | Director/Board Member | ||
| MOBERG PHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
Young Arab Leaders
 Young Arab Leaders Miscellaneous Commercial ServicesCommercial Services Young Arab Leaders is an organization based in Dubai, United Arab Emirates that focuses on educating and empowering the next generation of leaders in the Arab World. The Emirati company's goal is to turn innovative business ideas into a reality. The non-profit company was founded by Mustafa Ahmed Talaat Abdel Wadood. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| PROMIMIC AB | Medical Specialties | Director/Board Member Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal | |
| KCIF Fund Management AB | Director/Board Member Chairman Director/Board Member | ||
| Läkemedelsindustriföreningens Service AB | Director/Board Member | ||
Pharmathen International SA
 Pharmathen International SA Pharmaceuticals: MajorHealth Technology Pharmathen was founded in 1969 in Athens, as a private pharmaceutical company, and is focused on the development and marketing of pharmaceuticals, with a strong position in generics. With 3 state of the art research laboratories and 2 manufacturing units, Pharmathen is a completely vertically integrated company and its activities extend from the development of pharmaceutical products up to their distribution. The company's human resources works in the sectors of Research & Development (R&D), production and distribution of drugs to different countries worldwide. Now, Pharmathen's products are approved in all EU markets and distribution rights have been granted to the largest pharmaceutical companies in the world, particularly in Europe, the United States of America and Canada. | Pharmaceuticals: Major | Director/Board Member | |
S:t Eriks Ögonsjukhus AB
 S:t Eriks Ögonsjukhus AB Hospital/Nursing ManagementHealth Services S:t Eriks Ögonsjukhus AB operates eye hospitals. It specializes in corneal transplant; medical and surgical treatments of retina; oculoplastic surgery, ophthalmic oncology and pathology services; and medical contact lens service for infants and children. The company is headquartered in Stockholm, Sweden. | Hospital/Nursing Management | Director/Board Member | |
| DEDICARE AB | Other Consumer Services | Director/Board Member | |
NovaSAID AB
 NovaSAID AB Pharmaceuticals: MajorHealth Technology NovaSAID AB develops treatments for inflammation and pain in conditions such as rheumatoid arthritis. It discovers selective microsomal prostaglandin E synthase-1 (mPGES-1), and has also demonstrated its effect in animal models for pain and inflammation. The firm's approach is to prevent the pathological formation of prostaglandin E2 (PGE2) selectively, through the development of inhibitors of mPGES-1, the enzyme that is responsible for the formation of PGE2 during inflammation. Its mPGES-1 inhibition offers an approach for inhibiting pathological PGE2 production without adversely affecting other important prostanoids. The company was founded by Per-Johan Göte Jakobsson, Ralf Morgenstern, Bertil Samuelsson and Bengt Ingemar Samuelsson on October 26, 2004 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman | |
Biomatcell AB
 Biomatcell AB BiotechnologyHealth Technology Biomatcell AB operates as a holding company that commercializes inventions in the fields of biomaterial science and cell therapy by licensing its inventions and creating spin-off companies. It develops three-dimensional biomaterial scaffold geometries in bioactive ceramics and metals. It markets products and services based on research in the field of biomaterials and stem cells and patenting new ideas in the same area. The company was founded on May 11, 2004 and is headquartered in Gothenburg, Sweden. | Biotechnology | Director/Board Member | |
Hayati Commercial Brokers LLC
 Hayati Commercial Brokers LLC Finance/Rental/LeasingFinance Hayati Commercial Brokers LLC offers medical loans and patient financing services. It for services for dental, teeth whitening, or teeth implants; cosmetic surgery, plastic surgery, or hair implants; Eye, LASIK, or Vision surgery, and braces or orthodontics, fertility medical treatments, obstetrics and maternity medical treatments, and non elective medical treatments. The company was founded by Michael Matly and is headquartered in Dubai, the United Arab Emirates. | Finance/Rental/Leasing | Founder | |
| Eli Lilly Pharmaceuticals | Corporate Officer/Principal | ||
| Swedish Standards Institute | Director/Board Member | ||
Tigerconnect, Inc.
 Tigerconnect, Inc. Packaged SoftwareTechnology Services Tigerconnect, Inc. provides secure mobile messaging services. It offers secure, real-time mobile messaging for the enterprise, empowering organizations to work more securely. The company serves healthcare, enterprise, personal and developers. The company was founded by Jeffrey Albert Evans, Andrew A. Brooks and Brad Brooks in 2010 and is headquartered in Santa Monica, CA. | Packaged Software | Director/Board Member | |
KDev Oncology AB
 KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services KDev Oncology AB offers research and development of new cancer treatments. It provides know-how in the field of oncology. The company was founded by David Jern on July 14, 2005 and is headquartered in Solna, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Stiftelsen Swecare | Director/Board Member | ||
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| KD Incentive AB | Director/Board Member Director/Board Member | ||
| Sjukvårdsleverantörernas Service AB | Chief Executive Officer | ||
Swedish Medtech Service AB
 Swedish Medtech Service AB Miscellaneous Commercial ServicesCommercial Services Swedish Medtech Service AB is an association for medical technology in Sweden that brings together over 200 member companies to make Sweden the most attractive country for medical technology companies. The Swedish company's focus is on collaboration and they have a set of rules called "Samverkansreglerna". Anna Lefevre Skjöldbrand has been the CEO of the private company since 2005. | Miscellaneous Commercial Services | Chief Executive Officer | |
KDev Investments AB
 KDev Investments AB BiotechnologyHealth Technology KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and manages investments of companies in the fields of medicine. Its portfolio will include both early and clinical stage pharmaceutical assets, as well as some technology assets. The company was founded on January 10, 2012 and is headquartered in Solna, Sweden. | Biotechnology | Director/Board Member Director/Board Member | |
Perma Ventures AB
 Perma Ventures AB Investment ManagersFinance Perma Ventures AB provides financial advisory services. The private company is based in Stockholm, Sweden. | Investment Managers | Director/Board Member Director/Board Member | |
| MedTech Europe | Director/Board Member | ||
Arine, Inc.
 Arine, Inc. Hospital/Nursing ManagementHealth Services Arine, Inc. provides health care services. The company was founded by David de Vries and Yoona Kim and is headquartered in Dover, DE. | Hospital/Nursing Management | Director/Board Member | |
Sweden Medtech4health AB
 Sweden Medtech4health AB Miscellaneous Commercial ServicesCommercial Services Sweden Medtech4health AB is a strategic innovation program for medical technology that serves as a national arena for research and innovation on artificial intelligence for medical image analysis. The private company is based in Stockholm, Sweden. The Swedish company aims to be a catalyst for more medical technology ideas in healthcare, an efficient healthcare provider, and a strengthened medical technology industry. | Miscellaneous Commercial Services | Chairman | |
| COCIR | Director/Board Member | ||
| E-Hälsomyndigheten | Director/Board Member | ||
| Swecare Foundation | Director/Board Member | ||
AnaCardio AB
 AnaCardio AB Pharmaceuticals: MajorHealth Technology AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
invoX Pharma Ltd.
 invoX Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., invoX Pharma Ltd. is a British biopharmaceutical company. The private company is based in Kingston-upon-Thames, UK. The company was founded in 2021. Benjamin Toogood has been the CEO of the company since 2023. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
111 West Capital LLC
 111 West Capital LLC Investment ManagersFinance 111 West Capital LLC (111 West Capital) is a venture capital firm founded in 2021 by Andrew Brooks and Michael Matly. The firm is headquartered in Alpine, Wyoming. | Investment Managers | Founder |
Statistiques
Internationale
| Suède | 31 |
| Etats-Unis | 11 |
| Belgique | 4 |
| Emirats Arabes Unis | 3 |
| Suisse | 2 |
Sectorielle
| Health Technology | 12 |
| Consumer Services | 10 |
| Finance | 6 |
| Commercial Services | 6 |
| Technology Services | 4 |
Opérationnelle
| Director/Board Member | 233 |
| Corporate Officer/Principal | 72 |
| Chairman | 51 |
| Independent Dir/Board Member | 47 |
| Chief Executive Officer | 29 |
Relations les plus connectées
| Insiders | |
|---|---|
| Gunnar Magnus Modee Persson | 51 |
| James Noble | 39 |
| Per Gunnar Ernst Aniansson | 31 |
| Hans Lennart Rudolf Wigzell | 30 |
| Staffan Lindstrand | 25 |
| Karl Härfstrand | 23 |
| Christine Rankin | 23 |
| Ewa Björling | 21 |
| Anna Lefevre Skjöldebrand | 17 |
| Michael Matly | 14 |
| George Frederick Wilkinson | 14 |
| Björn Cochlovius | 14 |
| Theresa Tse | 14 |
| Pia Maria Hofstedt | 13 |
| John Öhd | 11 |
- Bourse
- Insiders
- Fredrik Järrsten
- Connexions Sociétés
